Doctors detail what we learned after the first season following the approval of RSV vaccines. The vaccine effectively prevented severe illness in older, but only 24 percent of eligible US adults received the vaccine, compared to 50 percent for flu shots. Better public awareness and improved vaccine access are needed to increase uptake.
